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Introduction
The risks of surgical complications from 
total thyroidectomy (TT) have deterred surgeons to 
practice it for more than a century ago when it was 
introduced as a major neck surgery [1], [2], [3]. It 
was the problem of hormonal replacement which was 
the main obstacle for doing the TT. With the rise of 
technical and technological possibilities of surgery 
at the end of 20th century, the question of doing TT 
arises from the need of adequate treatment if thyroid 
carcinoma only at the beginning of the 21st century the 
question of TT for benign disease arose to the level 
of controversy whether is it safe and complication 
free, along with the development of thyroid hormone 
substitute thyroxin and surgical technology for safer 
operative techniques [4].
Furthermore, the development of more accurate 
diagnostic possibilities as US m CT, US-guided FNAB 
and biochemical laboratories, and radioactive scans of 
thyroid gland, made better accuracy of different diagnosis 
strict and exact differentiation of benign and malignant 
pathology of the thyroid gland. Although the quantity 
of resected thyroid gland for benign disease is still 
controversial, increasing number of surgeons is prone 
to TT for benign disease such as multinodular euthyroid 
goiter (MNEG), multimodal toxic goiter (MNTG), Graves’s 
Abstract
BACKGROUND: The controversy of using total thyroidectomy (TT) in treatment of benign thyroid diseases still 
remains controversial over the rates of complication, mostly recurrence nerve palsy and hypocalcemia, compared to 
non-total thyroidectomies. The latest reports in this field of research showed that that the number of complications of 
TT is decreasing as the skills of surgeons increase. 
AIM: In this study, we reviewed 209 cases of total thyroidectomies for benign thyroid diseases where such surgery 
was indicated. The results were evaluated whether they support the previous reports that TT is save method of 
treatment of diffuse multinodular goiters, Graves’ disease thyroid adenomas with diffuse goiters and thyroiditis.
METHODS: Two hundred and nine patients, 36 males and 173 females, medium age 47 (17–77) operated with TT 
between 2016 and 2018 were included in the evaluation study. We evaluated the: Diagnosis, indications for operation, 
pre-operative medication administration, laryngeal recurrent nerve palsy, hypocalcemia, hypoparathyroidism, and 
patohistology findings. The follow-up for hypocalcemia and laryngeal nerve palsy was performed 1 year postoperatively.
RESULTS: The age of the patients was between 17 and 77 years, medium-range 47 years old. Of 209 patients, 
173 (83%) were female and 36 (17%) male with a gender ratio of 1:4.8 males to females. Diagnoses before 
surgery were established as follows: Multinodular euthyroid goiter (MNEG) n = 106 (48.80%), multinodular toxic 
goiter n = 12 (5.74%), Graves’s disease n = 6 (2.87%), adenoma with multinodular goiter n = 73 (34.92%), and 
n = 16 (7.65%) patients with thyroiditis. Recurrence laryngeal nerve palsy (RLNP) occurred in 6 patients (2.87%), 
temporary within 3 months after the operation in 4 patients (1.92%) and permanent palsy within 6 months and more 
after an operation in 2 patients (0.95%). Voice hoarseness immediately and within 1 month after the operation 
was registered in 32 patients (15.3%). RLNP and hoarseness were registered mostly in patients with pre-operative 
problems, mostly with extra big MNEG. One of the permanent injuries of RLN was bilateral and all others were 
one sided. All patients were operated with normal pre-operative vocal cord movement findings. Post-operative 
hypocalcemia was registered in 35 patients (16.74%). Temporary nonsignificant hypocalcemia in 10 (4.78%), 
temporary significant hypocalcemia in 17 (8.13%), temporary severe hypocalcemia in 6 patients (2.87%), and 
permanent hypocalcemia in 2 patients (0.95%).
CONCLUSION: Many studies have shown that the rate of complications is almost even for TT and NTT done for 
benign and malignant diseases of thyroid gland. Our data have shown that the risk of post-operative complications 
with TT is proportional to the number of complicated pre-operative findings of benign thyroid glands.
Edited by: Sasho Stoleski
Citation: Cholancheski R, Tolevska N, Qafjani A, Vela I, 
Kondov B, Kondov G, Jakupi N, Dzikovski I, Kokareva A, 
Srceva M, Tolevska M, Kartalov A, Arsovski Z, Vitanova A, 
Apostolovska N. Evaluation of Total Thyroidectomy for 
Treatment of Benign Diseases of Thyroid Gland. Open 
Access Maced J Med Sci. 2020 Apr 25; 8(B):166-170. 
https://doi.org/10.3889/oamjms.2020.3929
Keywords: Total thyroidectomy; Hypocalcemia; 
Recurrence nerve
*Correspondence: Risto Cholancheski, University Clinic 
for Thoracic and Vascular Surgery, Medical Faculty 
Skopje, University of “St. Cyril and Methodius” Skopje, 
Mother Theresa Str. 1000, Skopje, Republic of Macedonia. 
Tel.: +389-70-220-456. 
E-mail: colanceski@hotmail.com 
Received: 18-Oct-2019
Revised: 20-Dec-2019
Accepted: 20-Feb-2020
Copyright: © 2020 Risto Cholancheski, 
Natasha Tolevska, Ardit Qafjani, Ilir Vela, 
Borislav Kondov, Goran Kondov, Nexhati Jakupi, 
Igor Dzikovski, Anita Kokareva, Mimi Srceva, 
Marija Tolevska, Andrijan Kartalov, Zoran Arsovski, 
Andjela Vitanova, Nina Apostolovska
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0)
 Cholancheski et al. Evaluation of Total Thyroidectomy for Treatment of Benign Diseases of Thyroid Gland
Open Access Maced J Med Sci. 2020 Apr 25; 8(B):166-170. 167
disease, diffuse multimodal goiter with adenomas, and 
single gigantic goiter [5], [6], [7].
The work of a lot of surgeons across 
the world has shown that complication rates of 
permanent recurrent laryngeal nerve palsy 0.5–3%, 
and permanent hypoparathyroidism (HPTH) 1–2% 
following subtotal thyroidectomy (STT) are similar to 
those following TT [8], [9].
The disadvantages of STT, treating MNEG, and 
MNTG are that it does not reduce the risk of persisting 
symptoms with a high recurrence rate of 20–50% due 
to gland remnants and under L-thyroxine hormone 
suppression treatment [10].
These recurrences require repeated surgery 
which increases the possibility of 20 times greater risk 
of complications such as hypo parathyroidectomy and 
laryngeal recurrent nerve palsy (LRNP).
TT shortly eliminates the possibility of recurrent 
disease of the thyroid gland for MNTG and Graves’ 
disease and with the accurate hormonal replacement 
with L-thyroxine it is relatively easy to achieve a better 
outcome of treating MNTG, Graves’ disease and 
mixed thyroid adenomas, diffuse MNEG and MNTG, 
thyroiditis.
Still, no surgeon in the world can exactly 
sit where to cut the thyroid gland when it is diffusely 
nodulated.
For the past decade, a lot of papers have been 
published claiming excellent results with almost no 
complications with TT for benign disease. There is a 
general conclusion that TT is efficient and proved to be 
the first choice of surgery for benign thyroid diseases 
such as MNG euthyroid or toxic, Graves’ disease MDA 
with diffuse MNG, and diffuse thyroiditis.
The aim of thins paper is to evaluate whether 
TT can be carried out with low complication rates as 
low as a similar result in comparison to other proven 
surgery units.
Methods
We have performed a retrospective study of 
209 patients who underwent TT from 2015 to 2018 
at the University Clinic of Thoracic Surgery Mother 
Theresa in Skopje, Republic of Macedonia.
We extracted data of sex, age, thyroid disease 
details, pre- and post-operative evaluation of recurrent 
laryngeal nerve palsy (RLNP) rates, HPTH rates, 
patohistological findings, and surgery complication 
rates.
The patients with thyroid carcinoma were 
excluded from the study.
Pre-operative management
Clinical diagnosis in all patients included 
measurement of serum thyroxin T4, three iodine 
thyroxin T3, thyrotropin, thyroid antibodies, calcium 
serum levels, ultrasound US morphology, and SPECT 
scan with technetium-99m. A computed tomography 
scan of the neck was indicated for big retrosternal and 
thyroid glands with unclear morphology. Thyrosupresant 
therapy and beta-blockers therapy were indicated a 
month before the operative date for regulated toxic 
goiters and Graves’ disease.
Inclusion diagnosis
MNGT, MNGE, adenomas of the thyroid 
gland with diffuse MNG, Graves’ disease, and diffuse 
thyroiditis with suspicious solitary nodules with FBAV 
BETHESDA III and lower.
Surgical management
Dissection of the thyroid gland after suprajugular 
incision with muscle preservation, resection of the 
gland after lymph node LN, and parathyroid gland 
preservation using US FORCE TRIAD scissor and 
ULTRACISION ETHICON scissors with ligation of 
the inferior thyroid artery . Drainage of the neck was 
performed within 24 h. Discharging of the patient was 
on 3rd day after the surgery.
Post-operative measurement
Total serum calcium levels twice a day 
considering hypocalcemia as a Ca level ≤2, 0 mmol/L.
Considering temporary hypocalcemia in 
patients without symptoms, Ca level ≤2.0 mmol/l/2 days.
Temporary hypocalcemia with symptoms 
in patients with Ca level ≤2.0 mmol/l/2days needing 
supplementary 3 × 20 mg of Ca gluconate more than 
3 day.
Temporary hypocalcemia with Ca level ≤2.0 
mmol/l until the first control, which needed a supplement 
of Calcium 3 × 1 g/day tablets.
Temporary hypocalcemia with symptoms 
in patients Ca level ≤2.0 mmol/l. Three weeks after 
surgery needing 1 × 1 g/day supplementary calcium 
therapy in a period of 3 months.
Temporary hypocalcemia with symptoms Ca 
level ≤2.0 mmol/l 6 weeks after surgery and treated with 
D Vitamin solution 5000 i.u.
After 6 months of hypocalcemia with symptoms, 
we consider this as a state of permanent hypocalcemia.
The condition of LRN laryngeal recurrent nerve 
was passively evaluated by vocal cords movement 
immediately after extubation with video laryngoscopy 
B - Clinical Sciences Surgery
168 https://www.id-press.eu/mjms/index
and in case of stridor and ENT evaluation with video 
laryngoscopy for nerve palsy.
After getting negative histology for malignant 
disease within 5 days, L-thyroxine was administered in 
a starting dose of 25-mg/day.
The follow-up of the patient was conducted in 
collaboration with endocrinologist, internist, and ENT if 
needed after 1 week, 1 month, 3 months, and 1 year 
after the operation.
The patients were evaluated for eventual 
hypocalcemia and for supplementation Ca and Vitamin D3.
LNP was evaluated by the ENT doctor after 
6 months of voice hoarseness and aphonia of the 
patients.
Results
Two hundred nine patients with benign thyroid 
disease were surgically treated with TT at the University 
Clinic for Thoracic Surgery Mother Theresa – Skopje, 
between January 2015 and December 2018. The 
distribution of the patients through the years is shown 
in Table 1.
swallowing problems, tracheomalacia, and pressure to 
the surroundings of the thyroid gland.
The 18 patients with multinodular toxic goiters 
and Graves’ disease (8.61%) were preoperatively treated 
with antithyroid therapy 7 (38.88%) and 11 (61.12%) 
with antithyroid therapy and b-blockers therapy and 
were operated after the relapse of high thyroxin values, 
hyperthyroidism after medicamentos therapy.
RLNP occurred in 6 patients (2.87%), temporary 
within 3 months after the operation in 4 patients (1.92%), 
and permanent palsy within 6 months and more after 
operation in 2 patients (0.95%). Voice hoarseness 
immediately and within 1 month after the operation 
was registered in 32 patients (15.3%). RLNP and 
hoarseness were registered mostly in patients with pre-
operative problems, mostly with extra big MNEG. One 
of the permanent injuries of RLN was bilateral and all 
others were one sided. All patients were operated with 
normal pre-operative vocal cord movement findings.
Post-operative hypocalcemia was registered 
in 35 patients (16.74%). Temporary non-significant 
hypocalcemia in 10 (4.78%), temporary significant 
hypocalcemia in 17 (8.13%), temporary severe 
hypocalcemia in 6 patients (2.87%), and permanent 
hypocalcemia in 2 patients (0.95%).
Furthermore, temporary non-significant 
and severe hypocalcemia were registered more in 
patients surgically treated for MNEG and AMNG, while 
hyperparathyroidism with permanent hypocalcemia 
was registered in patients with Graves’s disease.
Post-operative complications as hemorrhage 
was finding in 2 patients ant no mortality was registered 
in Table 2.
The age of the patients was between 17 and 
77 years, medium-range 47 years old.
Of 209 patients, 173 (83%) were female and 
36 (17%) male with a gender ratio of 1:4.8 males to 
females.
Diagnoses before surgery were established as 
follows: MNEG n = 106 (48.80%), MNTG multinodular 
toxic goiter (MNTG) n = 12 (5.74%), Graves’s disease n 
= 6 (2.87%), adenoma with multinodular goiter (AMNG) 
n = 73 (34.92%), and n = 16 (7.65%) patients with 
thyreoiditis. All of the patient diagnoses were established 
by the endocrinologist and internal medicine doctors 
at Clinic for Endocrinology and Institute for Nuclear 
Medicine at Medical Faculty in Skopje.
The indication for surgical treatment was 
established by the surgeon in collaboration with 
endocrinologist and internist doctors who manage 
the diagnosis for surgical treatments. About 54% of 
the surgically treated patients have no pre-operative 
problems at the referral to surgery and most of them 
were with multinodular bilateral diffuse goiters while the 
other 46% were preoperatively marked like other who 
had operative indication due to ventilatory problems, 
Patohistology results were carried out in all 
patients, with 102 multinodular diffuse common goiters, 
MNTG 8, and MNTG with adenoma 4, Graves’ disease 
6, thyroiditis Hashimoto 17, and adenoma of the thyroid 
gland with multifocal diffuse goiter 73, atypical cell 
adenoma 7(9.59%), Hurthle cell adenoma 36 (49.31%), 
and papillary adenoma 30 (41.1%) (Table 3).
After a year follow-up of the patients at 1, 3, 
6, and 12 months postoperatively, no recurrence was 
observed and all patients were euthyroid with L-thyroxin 
treatment of supplementation.
The normal range of total calcium level was 
found in most of the patients, Ca 2.2–2.7 mmol/L. Severe 
Table 1: Distribution of the patients
Years n=patients
2015 45
2016 46
2017 54
2018 64
Total 209
Table 2: Complications after total thyroidectomy
Type of hypocalcemia No of patients
Hypocalcemia total 35 (16.74%)
Temporary non-significant 10 (4.78%)
Temporary significant 17 (2.87%)
Temporary severe 6 (0.95%)
Permanent 2 (0.95%)
Recurrent laryngeal nerve palsy
Temporary 4 (1.92%)
Permanent 2 (0.95%)
Hoarseness 32 (15.3%)
Bleeding 2 (0.95%)
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hypocalcemia, which occurred in 6 patients, resolved 
within 6 months with total Ca levels vary between 
1.7 and 2.1 mmol/L, treated with calcium 2–3.0 g. 
Ca-carbonate tablets/day and 5000 i.u. Vitamin D3/day 
and 2 patients have rest with permanent hypocalcemia 
more than 6 months until 1 year with total calcium levels 
between 1.7 and 2.0 mmol/L and were treated with 
Ca-carbonate tablets 2.0 g/day and Vitamin D3 5000 
i.u./day for a year.
Discussion
Until the retrieval of L-thyroxine, it was almost 
impossible to do TT except “out of need,” for gigantic 
obstructive goiters and carcinomas [11].
After the introduction of hormonal replacement 
and improvement of surgical techniques, the TT 
becomes possible at the end of the 21st century [12].
Although the procedure remains controversial, 
it is increasingly routinely performed for benign thyroid 
disease as for thyroid carcinomas [13].
The indication for TT arises from a logical fact 
that even accepted as benign MNGE, MNGT, and TA 
with diffuse MNG; GD is diffuse diseases of the thyroid 
gland, for who is impossible to say what part to be left 
in operation simply because there is no strict margin of 
the pathological changes of the gland itself [14].
We strongly believe and recommend TT for 
benign disease because of nonpossibility of recurrent 
disease, especially for diffuse MNG of the two lobes, 
GD and TA, with diffuse MNG of the rest tissue [15].
It is increasingly recognized that TT is 
appropriate for surgical treatment of BMNG T+E 
particularly when both lobes are involved [16].
The advantages of TT are release of symptoms, 
possibility of definitive histological finding, especially in 
suspicious cases of possible malignancy [17].
Reports say that there is a risk of 5–10% of 
malignancy to be found by incidence in MNG [18].
On the other side, the report of STT or 
unilateral thyroidectomy as a procedure with leaving 
residual glandular tissue, which exposes the patients 
to 20–40% risk of recurrent disease, which leads to 
repeated surgery, and which increases the possibility of 
complication [19].
The notorious fact is that the risk of surgical 
post-operative complication of non-TT is similar to that 
of TT and the risk of reoperation is 20 times bigger with 
non-TT [20].
The complication incidents (HPTH and RLNP) 
of TT have been reported high in some studies, where 
on the other side, there have been studies that report 
the low incident.
Low rates of complications have been reported 
in similar studies [21].
Furthermore, in the past two decades many 
reports have shown no significant difference in 
complication rates among patients who underwent 
TT compared with those who underwent non-total 
thyroidectomy (NTT) [22].
The percentage of complications seems 
to depend of the readiness and competence of the 
surgeon performing TT [23].
The number of TT in recent years has increased 
based on many research which slowly but surely has 
proven that new surgical techniques and technologies 
can increase surgeons capacity of safe TT.
In our study data suggests that the number of 
operated TT is increasing through the years. The age 
and gender frequencies are similar to those reported in 
literature and also the distribution of diagnoses for TT is 
similar to those reported in literature [24].
The relatively bigger number of LRNP and 
hypocalcemia in a patient operated with TT is due to 
a bigger percentage – 46% of indications marked as 
others, where the most significant reason for possible 
post-operative complications, after TT, is the late 
referral of the patients to the surgery unit with more 
pre-operative complications such as: Giganteus 
goiters, pressure to the adjacent structures in the neck, 
tracheomalacia, and problems arising from changed 
neck anatomy [25].
The distribution of RLNP, hypocalcemia, and 
patohistological findings is similar to the cited authors 
in the literature.
Conclusion
Having in mind that data from a number of 
studies across the world and from our own experience 
show that TT can be carried out safely with a low 
complication rate.
In recent studies, it is more obvious that the 
rate of complications of TT for benign thyroid disease 
is decreasing as surgeons skills increase as years go 
Table 3: Patohistology findings
Histology No of patients
Multinodular diffuse goiters euthyroid 102
Multinodular diffuse goiters 12
Diffuse 8
Adenomas 4
Graves’s disease 6
Multinodular diffuse goiters+adenomas 73
Atypical cell 7 (9.59%)
Hurthle cell 36 (49.31%)
Papillary adenoma 30 (41.1%)
Thyroiditis Hashimoto 17 (7.65%)
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by the percentage of complication rates is obviously 
decreasing in many reports.
Many studies have shown that the rate of 
complications is almost even for TT and NTT done for 
benign and malignant diseases of thyroid gland.
Our data have shown that the risk of post-
operative complications with TT is proportional to the 
number of complicated pre-operative findings of benign 
thyroid glands.
L-thyroxin is a good supplement for achieving 
euthyroid condition after TT.
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